SCHEMBL3873834

SCHEMBL3873834

C1CSC(c2nnn[nH]2)N1

nearest known ligand 0.38

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.38
TDP1 Q9NUW8 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
ALDH1A1 P00352 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL812418 0.63 CHRNB2 (0.37)
SCHEMBL18870955 0.62 MAPT (0.39) MAPTTDP1SMN1; SMN2ALDH1A1
SCHEMBL2996449 0.61 CHRNB2 (0.36)
SCHEMBL2998727 0.61 CHRNB2 (0.36)
SCHEMBL2996446 0.61 CHRNB2 (0.36)
SCHEMBL2991651 0.61 CHRNB2 (0.36)
SCHEMBL943172 0.61 MEN1 (0.39) SMN1; SMN2
SCHEMBL14505996 0.61
SCHEMBL4628774 0.61 CHRNB2 (0.36)
SCHEMBL2998728 0.61 CHRNB2 (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6548496-B2 Anticancer agents AMERICAN CYANAMID COMPANY 2003-04-15 US claimed
EP-1888567-B1 HETEROARYL-CARBOXYLIC ACID (SULFAMOYL ALKYL) AMIDE - DERIVATIVES AS FACTOR XA INHIBITORS SANOFI AVENTIS (FR) 2009-12-16 EP disclosed